Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes

Published:2012-08-31 Issue:3 Volume:27 Page:610-618
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

del Rey M,O'Hagan K,Dellett M,Aibar S,Colyer H A A,Alonso M E,Díez-Campelo M,Armstrong R N,Sharpe D J,Gutiérrez N C,García J L,De Las Rivas J,Mills K I,Hernández-Rivas J M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012253.pdf

Reference51 articles.

1. Cazzola M, Malcovati L . Myelodysplastic syndromes--coping with ineffective hematopoiesis. N Engl J Med 2005; 352: 536–538.

2. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.

3. Nolte F, Hofmann WK . Myelodysplastic syndromes: molecular pathogenesis and genomic changes. Ann Hematol 2008; 87: 777–795.

4. Herman JG, Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–2054.

5. Esteller M . Epigenetics in cancer. N Engl J Med 2008; 358: 1148–1159.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermethylation of GSTM5 and its effect on oxidation in myelodysplastic syndrome;iLABMED;2024-06

2. Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome;International Journal of Hematology;2022-12-27

3. What constitutes meaningful improvement in myelodysplastic syndromes?;Leukemia & Lymphoma;2022-06-14

4. Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients;The Pharmacogenomics Journal;2020-02-04

5. Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression;Genome Medicine;2019-12